In conclusion, a reliable prognostic model comprising efferocytosis-related genes (PDIA4, GNS, OSMR, MXRA8, PDLIM4, STC1, C9orf64, SLC16A13, and GZMB) for GBM patients was developed. The gene discussed is SLC16A13; the disease is glioblastoma.